Alaunos Therapeutics (TCRT) Interest & Investment Income (2010)
Alaunos Therapeutics (TCRT) reported Interest & Investment Income of $51250.0 for Q4 2010.
Alaunos Therapeutics (TCRT) Interest & Investment Income (2010) Analysis & Trends
Alaunos Therapeutics has reported Interest & Investment Income for 1 years, with the latest figure at $51250.0 in Q4 2010.
- For the quarter ending Q4 2010, Interest & Investment Income changed N/A year-over-year to $51250.0; the trailing twelve-month figure through Dec 2010 stood at $51250.0 (changed N/A YoY), and the FY2010 full-year result was $51250.0, changed N/A from the prior year.
- Interest & Investment Income for Q4 2010 stood at $51250.0.
- The five-year high for Interest & Investment Income was $51250.0 in Q4 2010, with the low at $51250.0 in Q4 2010.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 597,319.59 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 305,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -14.79 Mn |
| 10 | Alaunos Therapeutics | 4.31 Mn | 3.95 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2010 | 51,250.00 |